Blood · 2001 · 199 citations · 33 references
Life SciencesCell BiologyImmunologyCellular ImmunologyImmunotherapyTransplant ImmunologyCell-based ImmunotherapyCytotoxic T Lymphocyte ResponsesGraft RejectionGraft-versus-host DiseaseT Cell BiologyTransplant RejectionGraft Versus Host Disease ModulationGraft-versus-host Disease PathophysiologyT Cell - Mediated RejectionT Cell-based ImmunotherapyT-cell Mediated Rejection
Graft-versus-host disease (GVHD) is a major complication of allogeneic bone marrow transplantation. One strategy to treat GVHD is to equip donor T cells with a conditional suicide mechanism that can be triggered when GVHD occurs. The herpes simplex virus thymidine kinase (HSV-tk)/ganciclovir system used clinically has several limitations, including immunogenicity and cell cycle dependence. An alternative switch based on chemically inducible apoptosis was designed and evaluated. A chimeric human protein was expressed comprising an extracellular marker (DeltaLNGFR), the Fas intracellular domain, and 2 copies of an FK506-binding protein (FKBP). Primary human T lymphocytes retrovirally transduced with this construct could be purified to homogeneity using immunomagnetic beads. Genetic integrity of the construct was ensured by redesigning repetitive sequences. Transduced T cells behaved indistinguishably from untransduced cells, retaining the ability to mount a specific antiallogeneic immune response. However, they rapidly underwent apoptosis with the addition of subnanomolar concentrations of AP1903, a bivalent "dimerizer" drug that binds FKBP and induces Fas cross-linking. A single 2-hour treatment eliminated approximately 80% of T cells, and multiple exposures induced further apoptosis. T cells were eliminated regardless of their proliferation state, suggesting that the AP1903/Fas system, which contains only human components, is a promising alternative to HSV-tk for treating GVHD.
33
Séamus J. Martin, Chris Reutelingsperger, Anne J. McGahon et al. · The Journal of Experimental Medicine · 1995 · 2.9K citations · Full text
Inhibition of death receptor signals by cellular FLIP
Martin Irmler, Margot Thome, Michael Hahne et al. · Nature · 1997 · 2.6K citations · Full text
Gerrit Koopman, CP Reutelingsperger, GA Kuijten et al. · Blood · 1994 · 2.5K citations · Full text
Medicine, Cell Biology, Pathology +11
HJ Kolb, A Schattenberg, JM Goldman et al. · Blood · 1995 · 2K citations · Full text
Medicine, Hematology, Immunology +16